[Gene polymorphisms of renin-angiotensin-aldosterone system components and the progression of chronic kidney diseases].

UNLABELLED The renin-angiotensin-aldosterone system (RAAS) plays an important role in the pathogenesis of hypertension as well as cardiovascular diseases and chronic kidney diseases. Among the most frequently studied RAAS gene polymorphisms are the angiotensin-converting enzyme insertion/deletion (I/D), angiotensinogen M235T and angiotensin II receptor type 1 A1166C polymorphisms. A significant correlation was found between the I/D polymorphism and cardiovascular morbidity and mortality rates. However, there was no significant correlation between I/D, M235T, A1166C polymorphism and arterial hypertension. The role of I/D polymorphism in the development and progression of chronic kidney disease is also non-conclusive. However, DD genotype has been identified as relevant for loss of renal function both in patients with IgA nephropathy and in patients of Asian origin with diabetic nephropathy. The relationship between RAAS gene polymorphism and transplanted kidney function has not been confirmed in large prospective and retrospective studies. CONCLUSION there is no clear opinion concerning the influence of RAAS genotypes on the prevalence of post-transplant hypertension or erythrocytosis. Although a role of RAAS gene polymorphism in kidney function deterioration could not be ruled out, it is more likely that a variety of genetic and environmental factors influence the progression of chronic kidney diseases.

[1]  J. Chudek,et al.  Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis. , 2009, Transplantation proceedings.

[2]  M. Loh,et al.  Impact of genetic polymorphisms of the renin–angiotensin system and of non‐genetic factors on kidney transplant function – a single‐center experience , 2009, Clinical transplantation.

[3]  P. Ridker,et al.  Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study , 2008, Journal of hypertension.

[4]  J. Lunceford,et al.  ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[5]  K. Safranow,et al.  Influence of angiotensin I‐converting enzyme polymorphism on development of post‐transplant erythrocytosis in renal graft recipients , 2007, Clinical transplantation.

[6]  A. Courtney,et al.  Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  S. Chao,et al.  Association of Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism and IgA Nephropathy: A Meta-Analysis , 2006, American Journal of Nephrology.

[8]  J. Krieger,et al.  Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  E. Goloni-Bertollo,et al.  Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy. , 2006, Transplantation proceedings.

[10]  R. Ozaki,et al.  Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. , 2006, Kidney international.

[11]  A. Książek,et al.  Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  M. Arias,et al.  Prevalence of anemia in renal transplant patients: results from MOST, an observational trial. , 2005, Transplantation proceedings.

[13]  J. Vandenbroucke,et al.  ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. , 2005, Kidney international.

[14]  K. Chia,et al.  Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects , 2005, Diabetologia.

[15]  K. Safranow,et al.  The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney. , 2005, Transplantation proceedings.

[16]  T. Slowinski,et al.  No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  M. Haberal,et al.  Association of the Genetic Polymorphisms of the Renin-Angiotensin System and Endothelial Nitric Oxide Synthase With Chronic Renal Transplant Dysfunction , 2004, Transplantation.

[18]  T. Ishimitsu,et al.  Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  F. Moreso,et al.  Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies. , 2004, Journal of the American Society of Nephrology : JASN.

[20]  W. Winkelmayer,et al.  Pharmacoepidemiology of anemia in kidney transplant recipients. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  Y. Iwamoto,et al.  ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease. , 2004, Diabetes research and clinical practice.

[22]  K. Ivens,et al.  Influence of Genetic Polymorphisms of the Renin-Angiotensin System on IgA Nephropathy , 2004, American Journal of Nephrology.

[23]  A. Kausz,et al.  Anemia: A Continuing Problem Following Kidney Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  D. Abramowicz,et al.  Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  M. Margaglione,et al.  PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  R. Kazancioglu,et al.  Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. , 2003, Journal of nephrology.

[27]  V. Álvarez,et al.  Renin-angiotensin system polymorphisms and renal scarring , 2003, Pediatric Nephrology.

[28]  S. Bull,et al.  Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction1 , 2003, Transplantation.

[29]  E. Endreffy,et al.  ACE gene polymorphism and renal scarring in primary vesicoureteric reflux , 2002, Pediatric Nephrology.

[30]  S. Jeffery,et al.  Polymorphism of renin-angiotensin system genes in dialysis patients--association with cerebrovascular disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  A. Książek,et al.  [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. , 2002, Polskie Archiwum Medycyny Wewnetrznej.

[32]  B. Suwelack,et al.  Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition. , 2002, Transplantation proceedings.

[33]  H. Völzke,et al.  Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. , 2002, Chest.

[34]  M. Sever,et al.  The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients , 2002, Clinical transplantation.

[35]  J. Dudley,et al.  The deletion polymorphism of the ACE gene is not an independent risk factor for renal scarring in children with vesico-ureteric reflux. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  J. Nicod,et al.  Recipient ras gene variants and renal allograft function1 , 2002, Transplantation.

[37]  B. Brenner,et al.  Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. , 2001, Transplantation.

[38]  L. Gesualdo,et al.  ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. , 2001, Kidney international.

[39]  F. Frey,et al.  Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. , 2001, Kidney international.

[40]  H. Neumayer,et al.  Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients , 2001, Pediatric transplantation.

[41]  J. Redón,et al.  Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. , 2001, American journal of hypertension.

[42]  J. Pitha,et al.  ACE gene polymorphism and long-term renal graft function. , 2001, Clinical biochemistry.

[43]  T. Ishimitsu,et al.  The Deletion Allele of Angiotensin-Converting Enzyme Gene Polymorphism as a Cardiovascular Risk Factor in Patients Undergoing Long-Term Hemodialysis , 2000, Annals of Internal Medicine.

[44]  M. Capecchi,et al.  Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. , 2000, The Journal of clinical investigation.

[45]  F. Guillemin,et al.  Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men. , 2000, Journal of the American Society of Nephrology : JASN.

[46]  J. Cheung,et al.  EXPRESSION OF ANGIOTENSIN II TYPE I RECEPTOR ON ERYTHROID PROGENITORS OF PATIENTS WITH POST TRANSPLANT ERYTHROCYTOSIS1 , 2000, Transplantation.

[47]  A. Kastrati,et al.  Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. , 2000, Circulation.

[48]  A. Ricksten,et al.  Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  B. Antus,et al.  Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. , 2000, Kidney international.

[50]  Shokei Kim,et al.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. , 2000, Pharmacological reviews.

[51]  K. Thai,et al.  Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. , 1999, Kidney international.

[52]  J. Mosiewicz,et al.  [M235T polymorphism of human angiotensinogen gene in essential hypertension in Polish population]. , 1999, Polskie Archiwum Medycyny Wewnetrznej.

[53]  Freudenthaler,et al.  Angiotensin II increases erythropoietin production in healthy human volunteers , 1999, European journal of clinical investigation.

[54]  R. Schmieder,et al.  1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. , 1999, Circulation.

[55]  F. Soubrier,et al.  Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. , 1999, Hypertension.

[56]  R. Torra,et al.  Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  D. Glicklich,et al.  Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis. , 1999, Transplantation.

[58]  A. Bakkaloğlu,et al.  Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: importance of ACE polymorphism. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  Y. Tomino,et al.  Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients , 1999, Nephron.

[60]  R. Westendorp,et al.  The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. , 1999, Clinical nephrology.

[61]  A. Nocera,et al.  Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis. , 1999, Transplantation.

[62]  Y. Iino,et al.  Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[63]  D. Zeeuw,et al.  Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? , 1998, Journal of the American Society of Nephrology : JASN.

[64]  N. Perico,et al.  Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. , 1998, Journal of the American Society of Nephrology : JASN.

[65]  R. Kunz,et al.  Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. , 1998, Journal of the American Society of Nephrology : JASN.

[66]  W. Grzeszczak,et al.  Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. , 1998, Journal of the American Society of Nephrology : JASN.

[67]  P. Talmud,et al.  Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. , 1998, Diabetes.

[68]  G. Mayer,et al.  Angiotensin-Converting Enzyme Gene Polymorphism Determines the Antiproteinuric and Systemic Hemodynamic Effect of Enalapril in Patients with Proteinuric Renal Disease , 1998, Kidney and Blood Pressure Research.

[69]  P. Fernández-Llama,et al.  Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. , 1998, Kidney international.

[70]  R H Myers,et al.  Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. , 1998, Circulation.

[71]  A. Krolewski,et al.  Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. , 1998, Hypertension.

[72]  J. Connell,et al.  Evaluation of the angiotensinogen locus in human essential hypertension: a European study. , 1998, Hypertension.

[73]  A. Distler,et al.  Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[74]  T. Ogihara,et al.  Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. , 1998, American journal of hypertension.

[75]  D. Moczulski,et al.  Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. , 1998, Hypertension.

[76]  A. Piazza,et al.  Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. , 1998, Circulation.

[77]  Jean Tichet,et al.  Gene polymorphisms of the renin‐angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study , 1998, Journal of hypertension.

[78]  E. Ritz,et al.  A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension , 1997, Journal of hypertension.

[79]  G. Navis,et al.  Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status. , 1997, Kidney international. Supplement.

[80]  A. Krolewski,et al.  Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM , 1997, Diabetologia.

[81]  B. Julian,et al.  Angiotensin II stimulates proliferation of normal early erythroid progenitors. , 1997, The Journal of clinical investigation.

[82]  K. Thai,et al.  Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. , 1997, The Journal of clinical investigation.

[83]  S. Engeli,et al.  Angiotensin-converting enzyme genotype and renal allograft survival. , 1997, Journal of the American Society of Nephrology : JASN.

[84]  R. Schrier,et al.  Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. , 1997, Kidney international.

[85]  P. Amouyel,et al.  D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. , 1997, Circulation.

[86]  K. Kario,et al.  Hypertensive nephropathy and the gene for angiotensin-converting enzyme. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[87]  L. Tarnow,et al.  Genetics of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[88]  R. Ravazzolo,et al.  The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. , 1996, Journal of the American Society of Nephrology : JASN.

[89]  J. Connell,et al.  The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. , 1996, Hypertension.

[90]  W. Grzeszczak,et al.  Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy , 1996 .

[91]  S. Engeli,et al.  Angiotensinogen-M235T genotype and post-transplant hypertension. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[92]  A. Hamaguchi,et al.  Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. , 1996, Kidney international.

[93]  H. Parving,et al.  Nephrology Dialysis Transplantation Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy , 2005 .

[94]  B. Julian,et al.  Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. , 1996, Kidney international.

[95]  B. Kasiske,et al.  Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. , 1996, Kidney international.

[96]  H. Scheffer,et al.  Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy , 1996, The Lancet.

[97]  M. Fujishima,et al.  Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM , 1996, Diabetologia.

[98]  E. Arbustini,et al.  Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. , 1995, British heart journal.

[99]  I. Ichikawa,et al.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.

[100]  C. Ponticelli,et al.  No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[101]  M. Fornage,et al.  Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota , 1995, Human Genetics.

[102]  Z. Gaciong,et al.  ACE genotype and progression of IgA nephropathy , 1995, The Lancet.

[103]  T. Suehiro,et al.  Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. , 1995, Clinical nephrology.

[104]  D. Ganten,et al.  Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[105]  J. Connell,et al.  Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.

[106]  H. Parving,et al.  Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients , 1995, Diabetes.

[107]  N. Samani,et al.  Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty , 1995, The Lancet.

[108]  E. Ritz,et al.  Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. , 1995, Kidney international.

[109]  T. Ogihara,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[110]  D. Clayton,et al.  Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.

[111]  L. Tiret,et al.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.

[112]  T. Hostetter,et al.  Chronic transplant rejection. , 1994, Kidney international.

[113]  J. Lalouel,et al.  Angiotensinogen as a risk factor for essential hypertension in Japan. , 1994, The Journal of clinical investigation.

[114]  D. Cattran,et al.  Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[115]  G. Watt,et al.  The angiotensin I converting enzyme gene and predisposition to high blood pressure. , 1993, Hypertension.

[116]  D. Grobbee,et al.  Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study , 1993, Journal of hypertension.

[117]  T. Ogihara,et al.  Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. , 1993, Biochemical and biophysical research communications.

[118]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[119]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[120]  L. Tiret,et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.

[121]  J. Nelson,et al.  Plasma renin activity in renal transplant patients with hypertension. , 1991, American journal of hypertension.

[122]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[123]  P. Corvol,et al.  Structure of human angiotensinogen gene. , 1989, DNA.

[124]  C. V. Strihou,et al.  Hypertension after renal transplantation. , 1976, British medical journal.

[125]  M. Haberal,et al.  Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis. , 2004, Transplantation proceedings.

[126]  N. Madias,et al.  Posttransplant erythrocytosis. , 2003, Kidney international.

[127]  G. Remuzzi,et al.  ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. , 2000, Kidney international.

[128]  W. Grzeszczak,et al.  Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. , 2000, Kidney international.

[129]  A. Melk,et al.  Rethinking chronic allograft nephropathy: the concept of accelerated senescence. , 1999, Journal of the American Society of Nephrology : JASN.

[130]  G. Opelz,et al.  Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.

[131]  I. Borecki,et al.  Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. , 1997, Annals of epidemiology.

[132]  R. Kunz,et al.  Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension , 1997, Diabetologia.

[133]  K. Curnow,et al.  Human type-1 angiotensin II (AT1) receptor gene structure and function. , 1996, Clinical and experimental pharmacology & physiology. Supplement.

[134]  新井 誠.  In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis , 1995 .

[135]  F. Cambien,et al.  Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. , 1994, Diabetes.